The results of this study demonstrate that Chk1 downregulation and abrogation of G2 checkpoint are important regulatory steps in sensitivity and resistance to the cytotoxic effect of HDACi treatment in non-small cell lung cancer (NSCLC) cells. The gene discussed is CHEK1; the disease is non-small cell lung carcinoma.